Menveo vaccine supply shortage - Update from GSK

20 March 2018

GSK has released the following information about the private supply of Menveo:

“Menveo (Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine) supply will be constrained during 2018 due to manufacturing maintenance and improvement activities, and is currently out of stock. There is no impact on the safety or quality of the product.

At this stage, we are unable to confirm a return to supply date and expect to provide the next update on supply of this vaccine in January 2019. We expect the supply situation to normalise in 2019.

We regret the inconvenience this supply constraint may cause patients and healthcare professionals as we work to re-establish supply.

For medical enquiries regarding Menveo [Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine] please call GSK Medical Information on 1800 033 109.”